RFG
Invesco S&P Midcap 400 Pure Growth ETF
Invesco S&P Midcap 400 Pure Growth ETF is an exchange-traded fund incorporated in the USA. The Fund's objective is to replicate as closely as possible, before expenses, the performance of the S&P Midcap 400/Citigroup Pure Growth Index.
US
EQUITY
Rules-Based
MANAGEMENT STYLE
$ 313.8 M
ASSETS UNDER MGMT
35 bp
EXPENSES
Fund Basics
| Inception date | Mar 01, 2006 |
| Regulation | Open-Ended Fund |
| Fund Website | link... |
| Distributions | Quarterly |
| Currency | USD |
| Holdings Transparency | Full |
| Derivatives-based | No |
| Options available | Yes |
| Currency hedged | No |
| Fund of funds | No |
Top 10 Holdings
Complete list +
| HALOZYME THERAPEUTICS INC | 3.5 % |
| VALARIS LTD | 2.4 % |
| TECHNIPFMC PLC | 2.2 % |
| MEDPACE HOLDINGS, INC. | 2.2 % |
| FIVE BELOW | 1.9 % |
| INTERDIGITAL INC | 1.9 % |
| ARROWHEAD PHARMACEUTICALS, INC. | 1.9 % |
| EXELIXIS INC | 1.9 % |
| WOODWARD INC | 1.6 % |
| UNITED THERAPEUTICS CORP | 1.6 % |
Constituent Breakdown
| Number of holdings | 103 |
| Herfindahl-Hirschman Index | 143 |
| Wgt avg mkt cap (mns) | $12,138 |
| Large cap (>$10bn) | 57.9% |
| Mid cap ($2-10bn) | 35.5% |
| Small cap (<$2bn) | 0.0% |
| Developed mkts. | 94.4% |
| Emerging mkts. | 0.0% |
Sector Breakdown
Country Exposure
 |
UNITED STATES | 87.0 % |
 |
BRITAIN | 3.9 % |
 |
CAYMAN ISLANDS | 1.0 % |
 |
IRELAND | 1.0 % |
 |
CANADA | 0.7 % |
Historical Performance
Standardized Performance (as of 09/30/2026)
| YTD | 1 YR | 2 YR | 3 YR | 5 YR | 10 YR | 20 YR | Incep. | |
|---|---|---|---|---|---|---|---|---|
| Price Returns | 12.8% | 16.1% | 9.7% | 14.7% | 6.0% | 9.0% | 9.5% | 8.9% |
| Dividend Yield | 0.1% | 0.1% | 0.3% | 0.5% | 0.6% | 0.6% | 0.5% | 0.5% |
| Total Returns | 12.9% | 16.2% | 10.0% | 15.2% | 6.6% | 9.6% | 10.0% | 9.4% | Ann. Volatility | 21.2% | 20.1% | 21.6% | 20.8% | 23.1% | 23.2% | 23.6% | 23.5% |
Market Correlations
| versus... | Beta | R-squared |
| S&P 500 | 1.24 | 64% |
| MSCI EAFE | 0.95 | 56% |
| MSCI Emg Mkts | 0.62 | 62% |
Liquidity Measures
| Avg. volume (000) | 9 |
| ADV traded (mns) | $1 |
| Turnover | 0.2% |
| Avg. Bid/Ask (% of price) | 0.15% |
Technical Indicators
| 30d moving avg. (EMA) | $58.47 |
| Relative strength (RSI) | 42 |
| MACD/Signal | -0.74/-0.71 |
| Bollinger Bands (Upper/Lower) | $61.21/$55.46 |
| Short interest (% of AUM) | 0.3% |
Distributions
Top Ten Comparable ETFs only shown here. For an extended list become an Individual or Professional subscriber. Start your FREE trial
Comparable ETFs Based on Overlap
| Ticker | Fund Name | Overlap vs. RFG |
Expenses vs. RFG |
ALTAR Score™ vs. RFG |
|---|---|---|---|---|
| MDYG | State Street SPDR S&P 400 Mid Cap Growth ETF | 56.0% | -20 bp | +0.8% |
| IJK | iShares S&P Mid-Cap 400 Growth ETF | 55.1% | -19 bp | +0.8% |
| IVOG | Vanguard S&P Mid-Cap 400 Growth ETF | 54.9% | -25 bp | +0.7% |
| PAMC | Pacer Lunt MidCap Multi-Factor Alternator ETF | 34.8% | +25 bp | +4.7% |
| BUL | Pacer US Cash Cows Growth ETF | 31.2% | +25 bp | +1.8% |
| MDY | SPDR S&P Midcap 400 ETF Trust | 30.6% | -12 bp | +2.0% |
| XMMO | Invesco S&P MidCap Momentum ETF | 30.5% | -1 bp | 0.0% |
| SPMD | State Street SPDR Portfolio S&P 400 Mid Cap ETF | 29.3% | -32 bp | +2.2% |
| XJH | iShares ESG Screened S&P Mid-Cap ETF | 29.2% | -23 bp | +1.9% |
| IJH | iShares Core S&P Mid-Cap ETF | 29.0% | -30 bp | +2.2% |
Risk and Returns: RFG vs. Comps (1 YR)
Notes: Top 10 overlapping ETFs. Funds with insufficient history not shown. Some funds may overlap. Hover over data point for ticker symbol.
Content on this tab for Individual & Professional subscribers only. Start your FREE trial
Results & Estimates (USD)
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | ||
|---|---|---|---|---|---|---|---|---|---|
| Sales per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- | ||
| Earnings per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- | ||
| Dividends per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- | ||
| Book value per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- |
Return on Equity
Net Margins
Content on this tab for Individual & Professional subscribers only. Start your FREE trial
Valuation Metrics
| Fwd Est | 2025 | 2026 | 2027 | |
| Price-to-sales | --x | --x | --x | --x |
| Price-to-earnings | --x | --x | --x | --x |
| Price-to-cash flow | --x | --x | --x | --x |
| Price-to-growth | --x | --x | --x | --x |
| Price-to-book value | --x | --x | --x | --x |
| Yield | --% | --% | --x | --% |
Based on closing prices from 11/3/2026
Peer Group Comparison
Sample data. Subscribe for access.
Historical Valuation Trends Sample data. Subscribe for access.
Notes: Based on adjusted historical results for current fund constituents. May differ from results achieved by past fund constituents. Max P/E of 100x.
Some content on this tab for Individual & Professional subscribers only. Start your FREE trial
ETF Research Center Rating
4.7%
ALTAR SCORE™
34th
PERCENTILE
UNDERWEIGHT
ETFRC RATING
There are 1,395 funds in the US Equity category with an average
ALTAR Score™ of 5.5% and a standard deviation
of 2.1%. RFG's ALTAR Score™ is approximately -0.4 standard
deviations above the category average. This places RFG in the 34th percentile
among funds in the category.
Sell-Side Consensus
$73.84
PRICE TARGET
+30.7%
UPSIDE